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Abstract 
Objectives 
This study investigates the impact of extending the boundaries of economic evaluation in two dimensions: 
time horizon and inclusion of family effects. The context is postnatal mental health, where although 
advocates for investment often include longer-term and family problems in describing the burden of 
postnatal depression, econRPLFHYDOXDWLRQVDUHXVXDOO\OLPLWHGWRPRWKHUV¶HIIHFWVZLWKDUHODWLYHO\VKRUW
time horizon. This discrepancy may lead to suboptimal allocation of healthcare resources. 
Methods 
The question of whether such boundary extensions could make a difference to decision-making is explored 
using decision analytic models, populated with data from the literature, to estimate the cost-effectiveness of 
a hypothetical preventive intervention under alternate boundary-setting approaches. 
Results 
The results suggest that broader boundaries, particularly extension of the time horizon, could make 
substantial differences to estimated cost-effectiveness. Inclusion of family effects without extension of the 
time horizon had little impact, but where a longer time horizon was used, family effects could make a 
significant difference to the conclusions drawn from cost-effectiveness analysis.  
Conclusions 
Considerations in applying broader boundaries include the substantial resource requirements for evaluation, 
potential equity implications, relevance to decision-makers, methods for inclusion, and the interpretation 
and use of such results in decision-making. However, this context underscores the importance of 
considering not only caregiving but also family health effects, and illustrates the need for consistency 
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between the arguments presented to decision-makers and the analytical approach taken in economic 
evaluation.  
 
Introduction 
 
Although theory recommends that the boundaries of an economic evaluation should incorporate all 
important differences between the comparators (1), it may not always be obvious where to draw the 
boundaries; that is, which costs and outcomes to incorporate into a particular evaluation. In a discussion of 
decision analytic modelling for economic evaluation, Drummond et al. (1) suggest that boundary-setting 
³VKRXOG mainly be GULYHQE\WKHH[WHQWWRZKLFKH[WHQGLQJWKHERXQGDULHV«LVFRQVLGHUHGOLNHO\WRLPSDFW
on the cost-HIIHFWLYHQHVVRIWKHRSWLRQVEHLQJFRPSDUHG´ (p.290). Similarly, Gold et al. (2) state that effects 
which have little impact on the results can safely be excluded from the analysis.  
This paper addresses two issues of boundary-setting in the context of postnatal depression (PND): length of 
time horizon and the inclusion of family effects (quality of life and/or costs of relatives or significant 
others). Family effects encompass a third boundary: whether a health sector or wider perspective is taken. I 
outline why these issues are relevant in postnatal mental health, examine the impact of varying each 
boundary, and explore broader implications.  
Maternal PND is a common cause of postnatal morbidity (3, 4), producing a range of distressing and 
debilitating symptoms (5). Relevant to the choice of time horizon, approximately 30% are still depressed 
one to two years later (6), and PND is associated with later depression (7). Family effects are pertinent 
because children whose mothers had PND have higher rates of behavioural, emotional and cognitive 
problems (8, 9). While factors such as family environment, social support, biology, or adverse life events 
may explain these associations (10), a causal link is plausible. ChiOGUHQ¶VGHYHORSPHQWduring the postnatal 
period may be influenced by maternal stress, learned cognitions or behaviours, attachment problems and 
neurobiological processes (11). A series of reviews found that, after accounting for factors including later 
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maternal depression, the association between maternal PND and behavioural or emotional problems is 
ambiguous, but more reliable between PND and cognitive problems (8, 9, 12). These postulated family 
effects of PND could have significant economic implications. &KLOGUHQ¶Vhealth costs during the postnatal 
period are higher when mothers have PND (13). Children with cognitive, behavioural and emotional 
problems have lower quality of life and higher costs, affecting health, education, social services and justice 
sectors (14, 15). 
Advocates for investment in PND often describe the burden of PND as incorporating PRWKHUV¶ longer-term 
depression and FKLOGUHQ¶Vproblems (16-19), thereby implicitly assuming that intervening in PND could 
change factors beyond PRWKHUV¶ postnatal mental health. These broader costs and outcomes would be 
relevant to economic evaluation if their inclusion would vary the relative cost-effectiveness of comparators. 
In contrast, economic evaluations of PND interventions are usually limited to PRWKHUV¶ costs and outcomes 
with a time horizon of six to eighteen months. This discrepancy may lead to an allocation of healthcare 
resources that fails to maximise health. Women may be missing out on interventions that would be 
considered cost-effective if the appropriate boundaries were used, but conversely, if advocates influence 
decision-making using these arguments in the absence of economic evidence, overinvestment in PND 
interventions may result, with associated opportunity cost.  
 
Boundary setting for economic evaluation in PND 
 
Following economic theory and WKHµEXUGHQRI31'¶DUJXPHQWZRXOGalter the boundaries of evaluation in 
three dimensions from the status quo. First, and least controversially, it would entail use of a longer time 
horizon. Studies show that treatment for depression can improve the risk of recurrence (20) and that 
preventive approaches can be effective for at least up to two or three years (21).  
The second boundary variation would be to include family effects, assuming that some of an intervention¶V
value lies beyond the patient (22). While there is not yet consensus on how and when to include family 
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effects in economic evaluations, key decision-makers, including those in the UK and US, have taken the 
position that relevant family effects should be included (23, 24.). However, they have only been considered 
in limited contexts, including: prevention of HIV transmission, using a net monetary benefit approach (25); 
chronic heart failure, by summation of patient and carer quality-adjusted life years (QALYs) (26); 
children¶VYDFFLQDWLRQV, taking carer QALYs and productivity losses into account (27-29); and dementia, 
with patients and carers analysed separately (30). The inclusion of family effects might also affect the 
appropriate time horizon, since the impact of FKLOGUHQ¶V SUREOHPVFRXOGH[WHQGLQWRWKHFKLOG¶VDGXOWKRRG
(31). 
The third boundary variation, arising from the scope of DVVRFLDWHGFKLOGUHQ¶VSUREOHPV, shifts perspective 
from the health sector to public sector. Family effects relating to caregiving or altruism may only be 
relevant from a societal perspective (32), but family health effects may be relevant within a health sector 
perspective, particularly to a nation-wide healthcare payer (such as the UK¶V1+6). While some FKLOGUHQ¶V
problems affect the health sector, some involve other public sectors, such as education or social services.  
If all important differences between comparators should be captured, family effects could be relevant 
whenever WKHLQWHUYHQWLRQDIIHFWVIDPLO\PHPEHUV¶costs or outcomes (23, 32). PND interventions could 
modify FKLOGUHQ¶V risks through several pathways. Some could change FKLOGUHQ¶V outcomes even if the 
association between the outcome and PND is non-causal, such as by targeting family relationships (33) or 
parenting (34), or through spillover of the intervention by a mother learning and passing on skills to her 
child. To date, measures of family effects have largely been missing from studies of PND interventions, but 
the limited evidence suggests that treating PND leads to only slight improvement in child development, if 
any, even when the mother-child relationship improves (35, 36).  
One concern over the inclusion of family effects in economic evaluations is the potential for double 
counting of health-related quality of life (HRQoL), since the target individual could incorporate the effects 
RQIDPLO\PHPEHUV¶ZHOOEHLQJLQWRWKHLURZQ(32). However, family health effects, such as the posited 
effects of PND on children, are less likely than caregiving effects (37) to result in double counting (32).  
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Although we lack full data to inform the choice of boundaries for economic evaluation in PND, decisions 
on funding interventions must still be made. Decision analytic modelling allows synthesis of multiple 
sources of information and exploration of uncertainty surrounding the decision (38). I explore the potential 
impact of varying the boundaries for evaluation of PND interventions using alternate versions of a decision 
analytic model, using the available evidence to inform the methodological decision. The primary issue is 
not whether the modelled PND intervention is cost-effective, but rather whether altering the boundaries 
could make a substantial difference to decision-making.  
 
Methods 
 
Decision analytic models mathematically synthesise information regarding the probabilities, costs and 
outcomes for alternative courses of action (38), and contain structural, methodological and parameter 
uncertainty (39). Boundary setting could be considered a form of methodological uncertainty (asking which 
LVWKH³ULJKW´Dpproach for decision-making) or structural uncertainty (asking whether all pertinent 
repercussions are captured). Uncertainty regarding the inclusion of specific effects can be addressed by 
examining how much they alter the estimated cost-effectiveness (1, 2).  
Models populated from the literature were developed to evaluate a hypothetical PND intervention. Each 
boundary variation was modelled separately, since the purpose was to investigate each independently rather 
than to estimate an ICER for use in decision-making. 7KHEDVHPRGHOFDSWXUHGRQO\PRWKHUV¶costs and 
HRQoL with a time horizon of 12 months, using a decision tree structure, shown in Figure 1, since the time 
horizon was short (40).  This assumes no relevant effects on maternal HRQoL or costs beyond the postnatal 
period, nor in family members.  
[Figure 1 about here] 
The first variation added LQIDQWV¶KHDOWKVHFWRUFRVWVwithin this 12-month time horizon, assuming that 
interventions could influence these costs. An extHQGHGPRWKHUV¶PRGHOYDULHGWKHWLPHKRUL]RQXSWR
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years (the postnatal period plus 10 years), with Markov components added to the decision tree as shown in 
Figure 2 (41). This assumed that interventions could affect maternal depression beyond the first 12 months, 
but that after 11 years there were no relevant differences between control and intervention. Studies 
following up depression recurrence to 10 years suggest that risk of recurrence diminishes with time (42).  
The final variation assumed WKDWSUHYHQWLRQRIPDWHUQDO31'FRXOGDOWHUFKLOGUHQ¶VULVNVRIODWHUFRJQLWLYH
impairment, even without ongoing effects of the intervention on maternal depression, conceptualising the 
postnatal period as a key developmental stage in which maternal depression can have lasting effects on 
children. This model had an extended time horizon of up to 11 years, covering primary school age for 
children, as shown in Figure 3. The various model specifications are outlined in Table 1.  
[Table 1 & Figures 2-3 about here] 
The models were developed using TreeAge Pro 2015 software. The population of interest was postnatal 
women and their children in the UK, since much of the data came from that setting; this gave an explicit 
societal threshold of £20,000-30,000 per QALY for cost-effectiveness analysis in healthcare (23). A health 
sector perspective was taken, except for the FKLOGUHQ¶VPRGHO, which expanded to a public sector 
perspective to accommodate educational costs. A discount rate of 3.5% was applied to costs and QALYs 
(23)ZLWKGLVFRXQWLQJDSSOLHGEDFNWRWKHFKLOG¶VELUWK$OOFRVWVZHUHFRQYHrted to 2014 pounds sterling 
using OECD purchasing power parities (at which time £1.00=$US1.32) (43) and consumer price inflation 
data (44). Table 2 details the model parameters and their sources, taken from meta-analyses and systematic 
reviews where available, otherwise from the best quality available study data. The longest time horizon was 
11 years, based on long-term follow up studies of PND and due to scarcity of data beyond this point.  
[Table 2 about here] 
The diversity of parameter inputs required multiple sources of data and certain assumptions. Rates of 
comorbidity between cognitive, behavioural and emotional problems in children of women with PND were 
unavailable, and it would not be safe to assume that these are independent risks (45). The FKLOGUHQ¶V model 
was therefore restricted to cognitive impairment as this demonstrates the most consistent association with 
PRWKHUV¶31' (8, 9, 12). Model inputs were HRQoL for children with and without cognitive impairment at 
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age 11 (14), the additional risk of having special educational needs at the same age, conditional on maternal 
PND (46) and the excess costs associated with special education needs (47). 7KHODEHO³Vpecial educational 
QHHGV´LQWKHindicates some form of learning difficulty requiring additional resourcing (47). No cost or 
HRQoL impact of cognitive impairment entered the model until school age (five years).  
A preventive intervention was modelled to avoid the need to make assumptions about the impact of 
therapeutic interventions on children and particularly the mechanisms behind such impact, such as a 
reduced duration of exposure to depression and the timing of this exposure. The hypothetical intervention 
was intended to be sufficiently realistic without signifying any particular intervention. It modified only the 
risk of PND within the first two months, with subsequent events conditional upon this. The PND risk 
reduction was based on a meta-analysis of psychological and psychosocial interventions, which found the 
average risk reduction to be 7-34% (33). The control arm represented treatment as usual. As implied by the 
µburden of PND¶DUJXPHQW, it was assumed that successful prevention of PND had consequent benefits for 
children.  
One-way sensitivity analysis tested discount rates between 5% and zero. Combined parameter uncertainty 
was estimated using probabilistic sensitivity analysis, with 1,000 Monte Carlo simulations, to estimate the 
probability of cost-effectiveness at the NICE threshold of £20,000-30,000. The key result was the change in 
the estimated incremental cost-effectiveness ratio (ICER) between base and extended models.  
No specific funding was received to support this work. This paper is based on work using publicly 
available data. No ethics committee has reviewed this paper as there were no relevant ethical issues.  
 
Results 
 
The base PRGHOZKLFKLQFOXGHGRQO\PRWKHUV¶HIIHFWs in the first postnatal year, found the hypothetical 
preventive intervention to be not cost-effective (estimated ICER approximately £70,000/QALY). Figure 4 
displays the impact of the boundary variations on the LQWHUYHQWLRQ¶Vestimated cost-effectiveness. The first 
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variation, adding infant postnatal healthcare costs to the base model, resulted in an estimated ICER of just 
under £68,000/QALY. Extending the time horizon IRUPRWKHUV¶HIIHFWVmade a substantial difference, 
dropping the estimated ICER below the upper bound of the NICE threshold (£30,000/QALY) after the time 
horizon reached 3 years.  
[Figure 4 about here] 
7KHH[WHQGHGFKLOGUHQ¶VPRGHOZLWKa health sector perspective added FKLOGUHQ¶Vhealth costs in the first 
year, plus FKLOGUHQ¶V+54R/GXULQJ the primary school years (5 to 11 years). This model estimated the 
ICER to be £39,000/QALY at a time horizon of 11 years. Taking a public sector perspective included 
FKLOGUHQ¶V education sector costs and HRQoL during the primary school years. Under these specifications, 
the ICER dropped below the upper threshold at a time horizon of 10 years.  
One-way and probabilistic sensitivity analyses did not greatly alter the findings (see supplementary Table 
1). Varying the discount rate in one-way sensitivity analysis between a rate of 5% and no discounting made 
only slight differences to conclusions drawn about any of the boundary variations. The probability of cost 
effectiveness at the NICE threshold was, at most, approximately 50%, due to the considerable combined 
parameter uncertainty, even when a boundary variation had substantial effects on the point estimate of the 
ICER.  
 
Discussion 
 
These results suggest that setting the boundaries in line with advocacy arguments and economic theory 
could make a substantial difference to economic evaluation in PND. Of the extensions tested, the longer 
WLPHKRUL]RQIRUPRWKHUV¶HIIHFWVresulted in the largest reductions in the estimated ICER, was the least 
controversial methodologically, and required the least heroic assumptions regarding the effects of PND 
interventions. If developing PND expresses an underlying predisposition to depression that may be 
triggered by various life events, some preventive interventions (such as enhanced support) might not 
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change the woPDQ¶VODWHUULVNHowever, interventions which better equip women to cope with such life 
events might have ongoing benefit. At least, the results suggest merit in exploring whether potentially cost-
effective preventive interventions may be being overlooked due to the use of relatively short time horizons.  
The FKLOGUHQ¶V problems associated with PND and their substantial cost and HRQoL consequences might 
be quite persuasive in arguing for increased investment in PND. However, this study makes clear how 
much these arguments rely on assumptions regarding the effect of PND interventions on these broader 
risks, which are as yet largely unsupported in the literature.  
Without extending the time horizon, the inclusion of FKLOGUHQ¶V effects had little effect on the estimated 
cost-effectiveness of the intervention, so that for similar interventions, inclusion of family effects might not 
make a difference to decision-making if the time horizon is short. The impact of including FKLOGUHQ¶Vlater 
effects was limited by scarcity of data, but did show a substantial effect with the longer time horizon, 
despite the restrictive assumptions. This model only included one of the postulated effects of PND on 
FKLOGUHQH[DPLQLQJWKHIXOOUDQJHRIFKLOGUHQ¶VRXWFRPHVwhen evaluating PND interventions could be 
important for decision-making. The third boundary extension, broadening the perspective to include 
education sector costs, might be inappropriate where the focus is health sector decision-making, but could 
be relevant where such effects are considered by decision-makers as parWRIWKHµEXUGHQRI31'¶DUJXPHQW. 
The constraints in modelliQJFKLOGUHQ¶VHIIHFWVLQGLFDWH the need for more decisive evidence on these 
points.  
Because of simplifying assumptions in construction of the models the results should be interpreted with 
caution. The use of separate extended models meant that the joint uncertainty surrounding PRWKHUV¶DQG
FKLOGUHQ¶V effects was not estimable. It would be unsafe to assume that the results from each model could 
be combined by simple addition. For simplicity, the models did not include as outcomes either suicide 
related to depression or death due to other causes, as these are rare events in this population (48, 49). The 
use of cohort models did not allow for individual heterogeneity, such as past history of mental illness or 
severity of depression, to vary response to the intervention and or downstream risk.  
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The analysis relied on one strong assumption: that preventing maternal PND would neutralise the risks 
usually associated with PND, both for mothers and children. Although other pathways of association are 
likely to contribute, this strong assumption was consistent with WKHµEXUGHQRI31'¶ argument. Spillover of 
intervention effect (such as a mother passing on psychological skills to her child) was not modelled 
explicitly, but might contribute to this lowering of risk for children. In some women depression starts 
during pregnancy, and some interventions address risk during this period, so the analysis could be extended 
to include pregnancy, an additiRQDOSHULRGRISRWHQWLDOLQIOXHQFHRQFKLOGUHQ¶VGHYHORSPHQW 
This analysis has highlighted a lack of evidence regarding family effects of PND interventions. AlʘJanabi, 
Van Exel (27) suggest approaches to this data problem, including the collection of family data in trials of 
interventions. PND in fathers is more than twice as likely when the mother had PND (50). It would 
therefore be relevant to collect data on partners as well as children of women with PND in trials of both 
preventive and therapeutic interventions. This could LQIRUPWKHMRLQWPRGHOOLQJRIPRWKHUV¶DQGfamily 
PHPEHUV¶ORQJHU-term effects.  
An open question is how family effects might best be incorporated into economic evaluation. A single 
HVWLPDWHLQFRUSRUDWLQJPRWKHUV¶DQGIDPLO\HIIHFWVwould be needed for decision-making. These results are 
a first, preliminary examination of the impact of including family effects in PND evaluations, but indicate 
that such methodological work could be warranted. Bobinac et al. (51) suggest that presenting a combined 
result may be appropriDWHLIHDFKSHUVRQ¶VRXWFRPHLVPHDVXUHGXVLQJWKHVDPHLQVWUXPHQWAl-Janabi et al. 
(52) propose applying multipliers to the standard ICER formula to account for family health effects. The 
MRLQWDQDO\VLVRISDWLHQWV¶DQGFKLOGUHQ¶V costs and outcomes might be simpler within a cost-benefit 
framework. However, since many high-income countries (including the UK) focus on maximising health 
ZLWKLQWKHFRQVWUDLQWVRIDEXGJHWUDWKHUWKDQPD[LPLVLQJLQGLYLGXDOV¶XWLOLW\(53), cost-effectiveness 
analysis might better fit the needs of decision-makers. 
Many discussions of family effects address conditions affecting older adults (such as dementia) or children, 
rather than child-rearing adults, and portray family effects as mediated through caregiving or distress (51), 
not necessarily representing HRQoL (32). However, the mechanisms by which a PRWKHU¶V mental health 
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could affect her child are qualitatively different (11) and could require a different conceptualisation, 
relevant even within a health sector perspective. Family HRQoL might be particularly important for mental 
health interventions, being worse in families of someone with a mental illness, even after accounting for 
other health and sociodemographic factors (54). Larger decrements in IDPLO\PHPEHUV¶subjective 
wellbeing are associated with mental health than physical health problems (37), suggesting that the impact 
on families from intervening in mental health might differ from the average family impact of interventions 
within the healthcare system (52).  
A longer time horizon dictates a greater role for discounting, and more resource expenditure on gathering 
costs and outcomes. The inclusion of family effects would also demand more data on the effects of 
interventions on family risks, costs and HRQoL. Both extensions could require more complex models and 
introduce greater uncertainty around the results. 
Inclusion of family effects could appear to give higher priority to depressed women with children than 
those without children, since society is seen as getting better value for money from investing in mothers. 
Societies may be willing to prioritise those with dependents (55, 56). If family effects are only relevant in 
some areas, another consideration is how to compare an ICER incorporating family effects to an ICER 
based on individuals. Al-Janabi, van Exel (52) apply multipliers to both to the incremental effects of the 
intervention and to the threshold value for cost-effectiveness to account for average family effects 
displaced by new investment. To avoid misleading comparisons and allow decision-makers to use their 
own judgement regarding potential equity implications, family effects may fit best in supplementary rather 
than main analysis (32).  
Concluding remarks 
Postnatal mental health provides a novel context in which to discuss boundary setting for economic 
evaluation. It highlights the importance of using an appropriate time horizon and of considering family 
health effects, particularly for mental health problems and/or where the patient may be a parent of 
dependent children. It also illustrates the need for consistency between the arguments presented to decision-
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makers and the analytical approach taken in economic evaluation. The uncertainty surrounding these results 
indicates that similar uncertainty might surround existing decisions on investment in PND interventions.  
This first exploration of boundary setting in economic evaluation of PND interventions provides support 
for further endeavours to test and incorporate broader boundaries. The results encourage the use of a longer 
WLPHWLPHKRUL]RQIRUPRWKHUV¶ effects, whilst additional data and methodological work are needed to 
inform the inclusion of family effects. However, effectively ignoring these broader sets of costs and 
outcomes may mean that resources in postnatal mental health are misallocated, and that some women are 
not benefitting as they could from interventions which might be cost-effective.  
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Table 1. Alternate boundary setting approaches modelled 
Inclusions 
Mothers Children 
HRQoL Costs HRQoL Costs 
Base model Year 1 Year 1 (health) - - 
Base model with 
infant costs 
Year 1 Year 1 (health) - Year 1 (health)Á 
([WHQGHGPRWKHUV¶
model 
Years 1 - 11 Years 1±11 (health) - - 
&KLOGUHQ¶VPRGHO± 
health sector* 
Year 1 Year 1 (health) Years 5-11 Year 1 (health)Á 
&KLOGUHQ¶VPRGHO± 
public sector* 
Year 1 Year 1 (health) Years 5-11 
Year 1 (health) Á 
Years 5-11 (educ)  
*In the FKLOGUHQ¶VPRGHOPRWKHUV¶HIIHFWVDUHRQO\LQFOXGHGLQWKHILUVW\HDUDVLQWKHEDVHPRGHO 
Impact of cognitive disorders does not appear in the model until school age.  
Á,QIDQWFRVWVGHSHQGHQWRQPRWKHU¶V31'VWDWXVRQO\DYDLODEOHIRUWKHILUVW\HDU 
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Table 2. Model inputs & their sources in the literature 
Parameter PND No PND Distribution Derived from 
Probability parameters ± decision tree     
Maternal PND (from birth to 3 months) 0.13 Beta O'Hara and Swain (3) 
Maternal depression at 12 months 0.31 0.07 Beta Beeghly, Weinberg (57) 
6 month transition probabilities ± 0DUNRYFRPSRQHQWVH[WHQGHGPRWKHUV¶PRGHOV 
Depression to remission (time-dependent) 
0.54 in 1st 6mo ± 
0.09 after 5 years 
Beta Keller, Lavori (58) 
1st recurrence of depression after PND (time-
dependent) 
0.13 in 1st year ± 
0.02 after 12 years 
Beta Solomon, Keller (42) 
2nd recurrence of depression after PND (time-
dependent) 
0.23 in 1st year ± 
0.07 after 5 years 
Beta Solomon, Keller (42) 
1st depression in females 25-34yo   0.005 Beta Kessler, Mcgonagle (59) 
7UDQVLWLRQSUREDELOLW\DW\HDUVIRUFKLOGUHQ¶VPRGHO 
Child special educational needs 0.46 0.25 Beta Hay, Pawlby (60) 
HRQoL parameters ± PRWKHUV¶PRGHOV 
Depression during postnatal period 0.696  Beta Petrou, Morrell (61) 
Non-depressed during postnatal period  0.830 Beta Petrou, Morrell (61) 
Depression not in postnatal period 0.630 Beta Revicki and Wood (62) 
Remission not in postnatal period 0.860 Beta Revicki and Wood (62) 
Non-depressed not in postnatal period 0.878 Beta Ara and Brazier (63) 
HRQoL parameters ± FKLOGUHQ¶VPRGHO 
Child ± moderate cognitive impairment  0.884 Beta Petrou, Johnson (14) 
Child ± no cognitive impairment  0.957 Beta Petrou, Johnson (14) 
Cost parameters ± health sector (annual)*    
Mother, postnatal 1310 983 Gamma Petrou, Cooper (13) 
Infant, postnatal  888 860 Gamma Petrou, Cooper (13) 
Excess cost per case of depression  203 Gamma Thomas and Morris (64) 
Cost parameters ± education sector (annual)*   
Special educational needs, primary 9401 Gamma Boyle, Burton (65) 
No special educational needs, primary 7252 Gamma Boyle, Burton (65) 
Intervention parameters   
Reduction in risk of developing PND  0.66-0.93 Uniform Dennis and Dowswell (33) 
Cost* 180 ±25% Uniform Petrou, Cooper (66) 
Uptake 65.5% ±25% Uniform Woolhouse, Brown (67) 
*Costs expressed in in 2014 £ 
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Figure 1. Format of the base model 
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Figure 2. Format of Markov components in mothers¶ extended model 
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Figure 3. Extensions in the children¶s model 
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Figure 4. Impact of boundary changes on estimated ICER.  
 
 
ICER: Incremental cost-effectiveness ratio; QALY: Quality-adjusted life year 
